04:41 PM EDT, 03/27/2024 (MT Newswires) -- Johannes Jacob Pieter Kastelein, Director, Chief Scientific Officer, on March 26, 2024, sold 190,476 shares in Newamsterdam Pharma ( NAMS ) for $4,095,234.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1936258/000095017024037241/xslF345X03/ownership.xml